The global economic burden from the disease is highly significant, with about $200 billion annual spend [ 2 ].
← all excerpts
Assessment of measurement properties of the Brazilian-Portuguese version of the low back activity confidence scale (LoBACS) in patients with chronic low back pain.
1
—
—